首页> 美国卫生研究院文献>Advanced Science >Eskape Infection Control: Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections (Adv. Sci. 1/2020)
【2h】

Eskape Infection Control: Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections (Adv. Sci. 1/2020)

机译:Eskape感染控制:应对ESKAPE病原体对抗医院感染的注意事项和注意事项(Adv。Sci。1/2020)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Humans are belittled in their confrontation with the ever expanding galaxies of multidrug‐resistant bacteria. New antibacterial agents are annulled by the emergence of sophisticated bacteria‐resistant strategies that are beyond the imagination of the human mind. In their exploration for new antimicrobial strategies against ESKAPE pathogens, humans have to adopt a surrealistic mindset to unlock their subconscious resourcefulness. In article number , Ji‐Hua Chen, Franklin R. Tay, Li‐Na Niu, and co‐workers review antimicrobial research on ESKAPE pathogens over the past five years and provide prospective clinical applications.
机译:面对不断扩大的多重耐药细菌星系,人类面临的挑战越来越小。先进的细菌抗药性策略的出现使人类无法想象的新的抗菌剂被废除了。在探索针对ESKAPE病原体的新型抗菌策略时,人类必须采用超现实主义的思维方式来释放其潜意识的机智。在这篇文章中,陈继华,Franklin R. Tay,牛丽娜和同事回顾了过去五年中对ESKAPE病原体的抗菌研究,并提供了预期的临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号